![]() |
市場調查報告書
商品編碼
1547700
全球心包膜穿刺術市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Pericardiocentesis Procedures Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
預計到 2032 年,全球心包膜穿刺手術市場的市場規模將從 2023 年的 2.0857 億美元達到近 3.1399 億美元,2024-2032 年研究期間的複合年成長率為 4.65%。
心包膜穿刺術是一種侵入性手術,使用針和導管從心臟周圍稱為心包的囊中取出液體。該手術也稱為心包穿刺,用於檢測任何感染、發炎或癌症。它通常在醫院的重症監護室或心臟科進行。自體免疫疾病、甲狀腺功能低下、風濕熱、免疫抑制劑、胸部放射、癌症或腎衰竭可能導致液體積聚。此手術可用於治療心包填塞,這是一種危及生命的液體在心臟周圍快速積聚,削弱由心包積液引起的泵血的情況。
不健康的生活方式導致心血管疾病的高盛行率是該市場成長的主要原因。擴大採用微創手術來治療當今時代存在的幾種慢性病,以及全球老年人口的快速成長,將進一步推動市場成長。乳癌和肺癌病例的增加以及有利的報銷政策的可用性將推動市場成長。創新先進設備的開發和新產品的推出將有利於市場成長。這種低頻率、高風險的手術對於治療心包填塞(一種需要立即介入的危及生命的疾病)來說是一個極好的福音。然而,另一方面,缺乏熟練的專業人員和設備的高成本是市場成長的障礙。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球心包穿刺術市場的各個細分市場進行了包容性評估。心包膜穿刺術產業的成長和趨勢為本研究提供了整體方法。
心包穿刺術市場報告的這一部分提供了國家和區域層面細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的心包穿刺術市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心包穿刺術市場的主要參與者包括克利夫蘭診所、紐約長老會醫院、約翰霍普金斯醫院、聖喬治醫院、佛教慈濟醫學基金會、JW。歌德大學醫院、東京大學醫院、Mediclinic International、Apollo Hospitals Enterprise Ltd。開發、新產品發布和其他開發。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Pericardiocentesis Procedures Market is presumed to reach the market size of nearly USD 313.99 Million by 2032 from USD 208.57 Million in 2023 with a CAGR of 4.65% under the study period 2024-2032.
Pericardiocentesis procedure is an invasive procedure that uses a needle and catheter to remove fluid from the sac around the heart called the pericardium. This procedure, also called a pericardial tap, is done to detect any infection, inflammation, or cancer. It is usually performed in an intensive care unit or cardiology department in a hospital. Fluid buildup can occur due to an autoimmune disorder, hypothyroidism, rheumatic fever, immunosuppressants, chest radiation, cancer, or kidney failure. This procedure can be used to treat cardiac tamponade, a life-threatening rapid buildup of fluid around the heart that weakens its pumping caused by pericardial effusion.
The high prevalence of cardiovascular disorders due to unhealthy lifestyle practices is the leading cause of this market's growth. Increased adoption of minimally invasive procedures for treating several chronic conditions existing in this modern era and the geriatric global population's rapid growth will further propel market growth. The rise in breast and lung cancer instances and the availability of favorable reimbursement policies will boost the market growth. The development of innovatively advanced equipment and the launch of new products will benefit market growth. This low frequency, the high-risk procedure, is an excellent boon in treating cardiac tamponade, a life-threatening condition that demands immediate intervention. However, on the flip side, the lack of skilled professionals and the equipment's high costs are the barriers to market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pericardiocentesis Procedures. The growth and trends of Pericardiocentesis Procedures industry provide a holistic approach to this study.
This section of the Pericardiocentesis Procedures market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Pericardiocentesis Procedures market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pericardiocentesis Procedures market include Cleveland Clinic, NewYork-Presbyterian Hospital, The Johns Hopkins Hospital, Saint George Hospital, Buddhist Tzu Chi Medical Foundation, JW. Goethe University Hospital, The University Of Tokyo Hospital, Mediclinic International, Apollo Hospitals Enterprise Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.